Related Experiment Video
Updated: Feb 26, 2026
Modeling Stroke in Mice: Permanent Coagulation of the Distal Middle Cerebral Artery
Published on: July 31, 2014
Precision Stroke Animal Models: the Permanent MCAO Model Should Be the Primary Model, Not Transient MCAO
Devin W McBride1, John H Zhang2,3,4
1Department of Physiology & Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA, 92350, USA.
Abstract:
An argument for preclinical stroke research to make more use of the permanent middle cerebral artery occlusion (MCAO) model, rather than transient MCAO, is presented. Despite STAIR recommending permanent MCAO as the primary model, preclinical stroke research has not been listened. In 2012, Hossmann reported that 64% of the treatment studies for MCAO used prompt transient MCAO models and only 36% of the studies used permanent MCAO or gradual transient MCAO (i.e., embolic stroke model). Then, in 2014 and 2015, 88% of published basic science studies on large vessel occlusion used the transient MCAO model. However, this model only represents 2.5-11.3% of large vessel stroke patients. Therefore, the transient MCAO model, which mimics stroke with reperfusion, does not accurately reflect the majority of clinical stroke cases. Thus, once again, the argument for studying permanent MCAO as a primary model is made and supported.
Insights
Preclinical stroke research should prioritize the permanent middle cerebral artery occlusion (MCAO) model. Current transient MCAO models do not accurately represent the majority of clinical stroke cases, hindering effective treatment development.
Area of Science:
- Neurology
- Preclinical Stroke Research
- Cerebrovascular Diseases
Background:
- Stroke research frequently employs transient middle cerebral artery occlusion (MCAO) models.
- These models often involve reperfusion, which does not reflect the majority of clinical stroke scenarios.
Purpose of the Study:
- To advocate for increased utilization of the permanent MCAO model in preclinical stroke research.
- To highlight the discrepancy between current research models and clinical stroke patient populations.
Main Methods:
- Literature review of preclinical stroke research methodologies.
- Analysis of MCAO model usage in published studies (2012, 2014-2015).
- Comparison of MCAO model representation with clinical large vessel stroke patient data.
Main Results:
- A significant majority of preclinical studies utilize transient MCAO models (64% in 2012, 88% in 2014-2015).
- Transient MCAO models represent only a small fraction (2.5-11.3%) of clinical large vessel stroke cases.
- Permanent MCAO models are underutilized despite STAIR recommendations.
Conclusions:
- Transient MCAO models inadequately represent the majority of clinical stroke cases.
- Permanent MCAO models offer a more clinically relevant preclinical research approach.
- Prioritizing permanent MCAO research is crucial for developing effective stroke treatments.
